The Mid-Size Pharmaceutical Market Breakdown Data by Regions, Type, Manufacturers and Applications 2018

GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players, provides an in-depth assessment of the current trends in the global mid-size pharma market, along with growth strategies being pursued by these companies.

The report contains an overview of mid-size pharma companies in terms of overall revenue, R&D spending, number of pipeline and marketed products, number of employees, location of headquarters, year-on-year revenue and R&D expenditure. It also includes profiles of the top mid-size companies with overall revenue forecasts, and sales forecasts for top marketed products and late-stage pipeline products up to 2023.

Pharmaceutical companies with annual revenue in 2016 of between $1 billion and $10 billion are considered to be mid-size companies in the report. The mid-size pharma market is growing rapidly. Most of these companies are focusing heavily on developing a portfolio of generic products covering a variety of therapy areas and geographies. They have been competing with large pharma by developing generic products of high value innovative biologics after their patent expiry.

Request a Sample PDF Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1829067

Additionally, the top mid-size companies are involved in the end-to-end development of innovative products, although in these cases their focus is limited to specific therapy areas. A few mid-size companies diverge from the typical trends and are particularly focused on rare diseases. A wide range of strategies, such as mergers and acquisitions, in-house R&D, a shift towards high value generics and a focus on rare diseases, are being pursued by mid-size pharma companies to sustain and grow in the market.

This report provides key insights on the mid-size pharma industry, from data covering over 80 mid-size companies - both those focused exclusively on pharma, and those also involved in other divisions of healthcare, such as medical devices, in addition to pharma products.

Scope

How can the mid-sized pharma segment be defined in general, and what is its role in the industry?
Which mid-size pharma companies are on the leaders in terms of revenue, R&D expenditure, number of R&D products, marketed products and number of employees in 2016?
What is the revenue forecast for the key mid-size companies in 2023?
What are the key marketed products of the top mid-size pharma companies? What were the global sales figures in 2016 and what are the forecasts for 2023 for these products?
Which therapy areas are the key mid-size companies are focusing on? What are the global sales forecasts of late-stage pipeline products that are set to enter the market during the forecast period?
What was the year-on-year revenue growth and year-on-year R&D expenditure of key mid-size pharma companies between 2014 and 2016?
What are the key strategies followed by mid-size pharma companies to improve their revenue and push towards joining the large pharma segment?
What are the key challenges faced by mid-size pharma companies?

View Complete TOC with Tables and Figures index at: https://www.researchmoz.us/the-midsize-pharmaceutical-market-market-assessment-growth-forecasts-and-strategic-consolidations-for-key-players-report.html/toc

About Us

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators. 

Contact Us:

Mr. Nachiket

Albany NY - 12207

United States

Tel: +1-518-621-2074

Tel: 866-997-4948 (Us-Canada Toll Free)

Email: sales@researchmoz.us

tmrresearchblog.com

This release was published on openPR.